Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Clinical and Experimental Rheumatology|February 22, 2019
Novel biomarkers containing citrullinated peptides for diagnosis of systemic lupus erythematosus using protein microarraysYao Wang, Hailiang Liu, Yingmei Fu, et al.Journal of the National Cancer Center|July 22, 2025
Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022Jie Wu, Qianyun Jin, Yunmeng Zhang, et al.Journal of Global Health|April 10, 2025
Global landscape of early-onset thyroid cancer: current burden, temporal trend and future projections on the basis of GLOBOCAN 2022Qianyun Jin, Jie Wu, Caiyun Huang, et al.Scientific Reports|January 9, 2025
Severe obesity, high inflammation, insulin resistance with risks of all-cause mortality and all-site cancers, and potential modification by healthy lifestylesQianyun Jin, Siwen Liu, Yunmeng Zhang, et al.Plos One|September 30, 2014
MiR-122 directly inhibits human papillomavirus E6 gene and enhances interferon signaling through blocking suppressor of cytokine signaling 1 in SiHa cellsJunming He, Yuting Ji, Aimei Li, et al.Scientific Reports|January 14, 2025
Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screeningsYuting Ji, Yu Zhang, Hongyuan Duan, et al.Journal of Ovarian Research|October 27, 2024
Risk-stratified CA125 screening integrating CA125 trajectories, trajectory-specific progression and transvaginal ultrasound for ovarian cancerHongyuan Duan, Xiaomin Liu, Yu Zhang, et al.Frontiers in Cell and Developmental Biology|December 28, 2020
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory InjuryKaijiang Xia, Fang Zhu, Chengkui Yang, et al.Journal of the National Cancer Center|July 22, 2025
Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCANYunmeng Zhang, Yuting Ji, Siwen Liu, et al.Frontiers in Genetics|August 16, 2024
Preliminary effects of risk-adapted PSA screening for prostate cancer after integrating PRS-specific and age-specific variationXiaomin Liu, Hongyuan Duan, Siwen Liu, et al.Pageof 7